Chloroacetic Acid is a carboxylic or inorganic acid with defined pKₐ value governing its ionisation state across the pH range of biological fluids and pharmaceutical formulations. In pharmaceutical development, Chloroacetic Acid serves roles including counter-ion selection for API salt formation, pH adjustment and buffering in liquid formulations, and chemical reagent in API synthesis. Toxicological assessment for PDE derivation evaluates local irritancy effects on gastrointestinal mucosa, skin, and respiratory epithelium alongside systemic metabolic consequences of absorbed quantities, with the most sensitive endpoint in the most relevant study forming the POD.
Threshold of Toxicological Concern methodology provides a default PDE for Chloroacetic Acid when conventional toxicological data are insufficient for NOAEL-based derivation. Cramer class assignment follows the decision-tree algorithm: Class I structures with simple chemistry lacking reactive functional groups carry a TTC of 1800 µg/day; Class II in
